When Yahoo! launched a patent infringement suit against Facebook last month, the attack couldn't have come at a worse time for the leading social network. Not only is Facebook trying to look good in preparation of its upcoming IPO, but the company was woefully unprepared for a high-powered patent fight. According to Bloomberg Businessweek, Facebook only owns about 56 issued patents and 500 filed applications.
So Facebook had to make a choice:
- Come up with a legal strategy based on Yahoo!'s patents not really applying to Facebook's business, or
- shop around for a hefty cache of defensive patents.
Bloomberg and Reuters report that Facebook chose option No. 2. The company has reportedly bought 750 technology patents from IBM
There's no word on exactly what technologies the acquired patents might cover, and as the most prolific patent filer in the world, IBM's treasure trove includes a little bit of everything. And with such a wealth of assigned patents, IBM is no stranger to patent sales. In perhaps the most famous example, Google
Facebook's ideal outcome would be that Yahoo! sees this influx of nuclear ammunition and settles everything before Facebook's IPO date. Removing risks and uncertainty is good for stock prices. But don't hold your breath waiting for this to happen.
More likely, Facebook and Yahoo! go to war with dueling infringement claims, as is the norm in the tech industry these days. Some duels end quickly but others drag on for years. In one extreme example, Micron Technology
We can't even invest in Facebook yet, but the stock is sure to be a popular holding after the IPO. In the meantime, click here to grab a copy of our free report: "The Motley Fool's Top Stock for 2012." But hurry and grab it right now -- that special report won't be free forever.
Fool contributor Anders Bylund owns shares of Google and Micron but holds no other position in any of the companies mentioned. The Motley Fool owns shares of Yahoo! and Google. Motley Fool newsletter services have recommended buying shares of Yahoo! and Google. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinion, but we all believe that considering a diverse range of insights makes us better investors. Check out Anders' holdings and bio, or follow him on Twitter and Google+. We have a disclosure policy.
More from The Motley Fool
Is Gilead Sciences, Inc. a Buy in 2018?
Focus on the future rather than the past for this big biotech.
3 Dividend Stocks That Pay Out Over $8 Billion a Year
Can these huge companies keep the big dividend bucks flowing?
3 Growth Stocks Worth Owning for the Next 50 Years
These stocks have the potential to reward investors for decades to come.